Amrutanjan Health Care Shows Strong Financial Performance, Announces Highest Dividend in 5 Years

Amrutanjan Health Care, a smallcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company has shown a positive performance in this quarter, with a significant improvement in its financial score from -11 to 6 in the last three months.

One of the key factors contributing to this positive performance is the growth in Profit Before Tax (PBT) less Other Income, which has increased by 126.05% year on year to Rs 11.89 crore. This trend is expected to continue in the near term, indicating a strong financial outlook for the company.

Another noteworthy aspect is the growth in Profit After Tax (PAT), which has increased by 72.3% year on year to Rs 11.80 crore. This is a clear indication of the company's efficient management and strong financial position.

In addition, Amrutanjan Health Care has also announced a dividend per share (DPS) of Rs 4.60 annually, which is the highest in the last five years. This shows the company's commitment to distributing higher dividends from its profits.

Based on these positive financial results, MarketsMOJO has given a 'Buy' call for Amrutanjan Health Care's stock. With its strong financial performance and promising outlook, the company is poised for growth in the pharmaceutical industry. Investors can consider adding Amrutanjan Health Care to their portfolio for potential returns.